Interview with Janusz Obukowicz, Managing Director, Pharmaceutical Reearch…
Would you start by giving our readers a brief outline of the history of the PRI? In 1952 the institute was established as a research and development (R&D) centre for…
Address: ul. A & F Radziwill 9 , 05-850 Ozarow
Tel: (4822) 679-51-35
Web: http://www.vipharm.com.pl/
Vipharm S.A. is a Polish pharmaceutical company focusing for last 10 years on research, production and sale of specialist drugs.
Our drugs meet the requirements of Good Manufaktury Practice and Good Distribution Practice.
Safety and efficacy of our drugs has been confirmed by bioequivalence and bioavailability studies.
Vipharm S.A. still obtains excellent economical results, and is a successful competitor of the biggest manufacturers of medicines both on Polish and foreign markets. It has a leading position in respect of the value of sale and the amount of sold packages on Polish pharmaceutical market.
High quality of our drugs has been distinguished with Certificate of Innovation 2005 from PolishAcademy of Science and since 2008 year by year Vipharm S.A. has been distinguished with Certificate of Quality from PolishCenter of Research and Certification .
Scientific research over medicines investing after 10 years of activities in 2008 Vipharm started activity on international markets, on the territory of Czech, Slovakia, Hungary and Germany create trade companies Vipharm Slovakia s.r.o. Vipharm Hungary Kft. and Vipharm GmbH.
Vipharm S.A. specializing in the development, manufacturing and marketing of branded equivalents that help improve the quality of human life. As a manufacturer of medicines, it offers unique products, manufactured in modern, friendly area, according to GMP rules and the requirements of worldwide pharmacopoeias.
Our offer covers a wide range of therapeutic areas. However, we mainly concentrate on the therapy of Oncology and Central Nervous System diseases.
Would you start by giving our readers a brief outline of the history of the PRI? In 1952 the institute was established as a research and development (R&D) centre for…
You became president of the board at Medicover in Poland only a while ago and previously your previous experience was in high-profile management but not in healthcare. Do you now…
IMS ‘lives and breathes the pharma industry’ and it is stimulating to come from other forms of consultancy to IMS. You have worked in various businesses. What motivated you to…
You were the CEO for three different companies and the founder of Sensilab and then you acquired Polfa Lodz. Could you relate to our readers the development of your career…
As we are just entering 2011, could you share with us the results of the Polish affiliate in 2010? 2010 was for Ferring Poland a year of reconstruction. The affiliate…
Adamed was founded in 1986 by your father, Mr. Marian Adamkiewicz. The company is today still fully-owned by your family, which is remarkable in such an industry, where family-run businesses…
You joined Merck in September 1996, took gradually increasing positions at Merck, from Medical Representative (1996 – 1998), to Sales and Marketing managing positions and you were ultimately appointed Managing…
You have been appointed at the head of Pfizer Poland last December. 2010 is a hot year for the group – even very hot for some of the top management…
Apart from Poland being a 40 million population market, with double digit growth, Mr. Kuczynski of Pierre Fabre was telling us that the main opportunity of the Polish market lies…
What is PharmaExpert’s role in the Polish pharmaceutical industry? The information that PharmaExpert gathers enables us to give good insight about the evolution of the pharmacists market, the evolution of…
See our Cookie Privacy Policy Here